Burning Rock (BNR) news

Recent news

ImportantBurning Rock Biotech shares up 13% premarket after Dizal's non-small cell lung cancer diagnostic receives China marketing approval

Burning Rock Biotech shares up 13% premarket after Dizal's non-small cell lung cancer diagnostic receives China marketing approval Burning Rock Biotech (NASDAQ:BNR), a leading biotechnology company specializing in the development of innovative diagnostic solutions, experienced a significant surge…

AInvest Wire · Oct 11, 2024

Burning Rock Biotech Q4 EPS $(0.22) Up From $(0.31) YoY, Sales $17.10M Down From $20.62M YoY

AInvest Wire · Mar 28, 2024

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by